- Report
- August 2024
- 168 Pages
Global
From €2204EUR$2,500USD£1,907GBP
- Report
- August 2024
- 184 Pages
Global
From €2204EUR$2,500USD£1,907GBP
- Report
- July 2024
- 182 Pages
Global
From €2204EUR$2,500USD£1,907GBP
- Report
- May 2024
- 191 Pages
Global
From €2204EUR$2,500USD£1,907GBP
- Report
- March 2024
- 170 Pages
Global
From €2204EUR$2,500USD£1,907GBP
- Report
- February 2024
- 150 Pages
Global
From €2204EUR$2,500USD£1,907GBP
- Report
- November 2023
- 166 Pages
Global
From €2204EUR$2,500USD£1,907GBP
- Report
- July 2021
- 120 Pages
Global
From €2204EUR$2,500USD£1,907GBP
From €2204EUR$2,500USD£1,907GBP
- Report
- October 2020
- 120 Pages
Global
From €2204EUR$2,500USD£1,907GBP
- Report
- April 2023
- 110 Pages
Global
From €4187EUR$4,750USD£3,623GBP
- Report
- May 2022
- 52 Pages
Global
From €2204EUR$2,500USD£1,907GBP
- Report
- January 2024
- 150 Pages
Global
From €3394EUR$3,850USD£2,937GBP
€4275EUR$4,850USD£3,699GBP
- Report
- February 2024
- 184 Pages
Global
From €3394EUR$3,850USD£2,937GBP
€4275EUR$4,850USD£3,699GBP
- Report
- August 2023
- 150 Pages
Global
From €3394EUR$3,850USD£2,937GBP
€4275EUR$4,850USD£3,699GBP
- Report
- April 2023
- 150 Pages
Global
From €3394EUR$3,850USD£2,937GBP
€4275EUR$4,850USD£3,699GBP
- Report
- April 2024
- 122 Pages
North America
From €1322EUR$1,500USD£1,144GBP
- Report
- April 2024
- 137 Pages
Africa, Middle East
From €1322EUR$1,500USD£1,144GBP
- Report
- April 2024
- 135 Pages
Europe
From €1322EUR$1,500USD£1,144GBP
- Report
- April 2024
- 283 Pages
Global
From €3173EUR$3,600USD£2,746GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more